Honeymoon Rally Fails to Withstand Taiwan Market Turbulence: EverYoung Health Plunges Over 20% on First Trading Day, Backed by Terry Gou

EverYoung Health (7835) debuted on Taiwan's Emerging Stock Board today at TWD 49.13 per share. The stock briefly rose to TWD 50 in early trading but succumbed to heavy selling pressure amid broader market turmoil, declining over 22% to a temporary low of TWD 38.2 by the time of reporting.

EverYoung Health is one of the few domestic technology platforms capable of integrating preventive medicine with digital health. Its shareholder base includes prominent names such as the National Development Fund, Hon Hai (Foxconn), and the Yonglin Foundation. Terry Gou, founder of Hon Hai, holds approximately 23% of shares, making him the largest shareholder, while Cifco Foods holds 15%, ranking as the second-largest shareholder.

Beyond continuous investment in personal data privacy protection and cold-start capabilities, EverYoung Health possesses core technologies including a highly controllable AI architecture and expert knowledge logic. These enhance the credibility of its technology and reliability of its services, forming a key technical advantage for its H2U AI Health Service.

Dr. Chen Chun-Chia, Chairman of EverYoung Health, stated that 'health is a marathon,' emphasizing the company's commitment to deepening health data integration and AI applications. The goal is to help enterprises, medical institutions, and individuals transform health data into more precise, timely, and actionable health decisions. The company also aims to optimize recurring revenue streams such as SaaS subscriptions and health data services to strengthen long-term operational resilience.

EverYoung Health emphasized its future vision of building an Asian health tech cooperation ecosystem with Taiwan as the core.

According to market research data, Taiwan's digital health market has grown from approximately TWD 41.2 billion in 2020 to around TWD 55 billion in 2023, with a projected compound annual growth rate (CAGR) of about 11% over the next three years. Notably, the AI healthcare application segment is expected to grow at a CAGR of 48.1%.

EverYoung Health highlighted that alongside market growth, government initiatives such as the NT$50 billion 'Precision Health 5-Year Plan,' the 'Healthy Taiwan Deepening Project,' the 'Three Highs Prevention 888 Project,' the 'Everyone’s Doctor Project,' and the promotion of Health Coins are expected to continuously drive demand for digital health and AI health services.

In terms of financial performance, EverYoung Health reported consolidated revenue of TWD 513 million in the previous year, a year-on-year increase of 20.81%. Revenue for the first half of this year reached TWD 207 million, up 0.68% year-on-year.

Looking ahead, EverYoung Health emphasized its commitment to deepening its first-party health data ecosystem, positioning itself as a connector in the health industry linking healthcare, enterprises, technology, and individuals. The company aims to expand AI-driven health decision-making applications, transforming health data into tangible health value. With Taiwan as its core, it plans to expand into Asian markets, exporting Taiwan's health data integration capabilities and digital health platform expertise to build a regional health tech cooperation ecosystem.